• (Add Comment)

Gast-Reg 200 mg 30 tablets

For parenteral use: symptomatic treatment of severe pain manifestations in functional disorders of the gastrointestinal tract; treatment of postoperative paralytic ileus and in preparation for X-ray and endoscopic examinations.

Buy

Product quantities

• Sharm El Sheikh: In stock
• Hurghada: In stock
• Al alamein: In stock
• Cairo: In stock

Form of Release: Tablets

Product Categories: Digestion

Gast-Reg 200 mg 30 tablets

Composition:

Each tablet contains:

  • Trimebutine maleate 200 mg.

Excipients:

  • Lactose monohydrate (Lactopress) (milk sugar), pregelatinized starch (Starch 1500), colloidal silicon dioxide (Aerosil), magnesium stearate, talc.

Properties:

Trimebutine acts on the enkephalinergic system of the intestine and regulates gastrointestinal motility. By acting on peripheral δ-, μ-, and κ-receptors, including those directly located on the smooth muscles throughout the gastrointestinal tract (GIT), it normalizes motility without affecting the central nervous system. Thus, trimebutine restores the normal physiological activity of intestinal muscles in various gastrointestinal disorders associated with motility disturbances.

By normalizing visceral sensitivity, trimebutine also provides analgesic effects in cases of abdominal pain syndrome.

Indications:

For oral administration:

  • Symptomatic treatment of pain associated with functional disorders of the gastrointestinal and biliary tract.

For parenteral use:

  • Symptomatic treatment of severe pain due to functional GIT disorders;

  • Treatment of postoperative paralytic ileus;

  • Preparation for radiological and endoscopic examinations.

Dosage and Administration:

The optimal dosing regimen is determined by the physician. The specific dosage form used must match the indicated use and dosage instructions.

Individual dosage:

  • Daily dose for oral use — up to 300 mg (one 100 mg tablet 3 times per day).

  • The dose can be increased up to 600 mg per day (one 200 mg tablet 3 times per day).

Contraindications:

  • Hypersensitivity to trimebutine.

  • Pregnancy.

  • Lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

Precautions:

A course of treatment for irritable bowel syndrome at a dose of 600 mg/day for four weeks during the acute phase, followed by 300 mg/day for 12 weeks, helps prevent recurrence of the condition.

Adverse Reactions:

Gastrointestinal: dry mouth, unpleasant taste, diarrhea, dyspepsia, nausea, constipation.
Nervous system: drowsiness, fatigue, dizziness, headache, restlessness, sensation of heat or cold.
Allergic reactions: skin rash.
Others: menstrual disorders, painful breast enlargement, urinary retention.

Storage Conditions:

Store in a dry place at temperatures not exceeding 25°C.

Packaging:

A cardboard box containing 1, 2, or 3 blister packs of 10 tablets each, and a paper insert (instructions for use).

Active Ingredients:

No comments yet. Be the first to write one.

Leave a Comment

Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.

I'm not a robot

Articles about the product